−1.6321 USD
−25.99 M USD
0.00 USD
15.79 M
About Unity Biotechnology, Inc.
Sector
Industry
CEO
Craig R. Jalbert
Website
Headquarters
South San Francisco
Founded
2009
ISIN
US91381U2006
FIGI
BBG00KJXM4R0
Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.
Related stocks
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of UNBX is 0.0725 USD — it has decreased by −3.33% in the past 24 hours. Watch Unity Biotechnology, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Unity Biotechnology, Inc. stocks are traded under the ticker UNBX.
UNBX stock has risen by 30.87% compared to the previous week, the month change is a −30.62% fall, over the last year Unity Biotechnology, Inc. has showed a −95.66% decrease.
UNBX reached its all-time high on Sep 17, 2018 with the price of 2,456.0000 USD, and its all-time low was 0.0487 USD and was reached on Aug 1, 2025. View more price dynamics on UNBX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
UNBX stock is 11.72% volatile and has beta coefficient of 1.42. Track Unity Biotechnology, Inc. stock price on the chart and check out the list of the most volatile stocks — is Unity Biotechnology, Inc. there?
Today Unity Biotechnology, Inc. has the market capitalization of 1.25 M, it has decreased by −6.25% over the last week.
Yes, you can track Unity Biotechnology, Inc. financials in yearly and quarterly reports right on TradingView.
UNBX earnings for the last quarter are −0.43 USD per share, whereas the estimation was −0.40 USD resulting in a −7.50% surprise. The estimated earnings for the next quarter are −0.17 USD per share. See more details about Unity Biotechnology, Inc. earnings.
Unity Biotechnology, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
UNBX net income for the last quarter is −7.30 M USD, while the quarter before that showed −8.44 M USD of net income which accounts for 13.48% change. Track more Unity Biotechnology, Inc. financial stats to get the full picture.
No, UNBX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Sep 2, 2025, the company has 16 employees. See our rating of the largest employees — is Unity Biotechnology, Inc. on this list?
Like other stocks, UNBX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Unity Biotechnology, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Unity Biotechnology, Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Unity Biotechnology, Inc. stock shows the sell signal. See more of Unity Biotechnology, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.